Primary signet cell carcinoma of the prostate: a case report
Memo - Magazine of European Medical Oncology, cilt.10, sa.2, ss.115-117, 2017 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 10 Sayı: 2
- Basım Tarihi: 2017
- Doi Numarası: 10.1007/s12254-017-0327-3
- Dergi Adı: Memo - Magazine of European Medical Oncology
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.115-117
- Anahtar Kelimeler: Androgen deprivation, Carcinoma, Hormonal treatment, Prostate, Signet cell
- Erzincan Binali Yıldırım Üniversitesi Adresli: Hayır
Özet
Primary signet cell carcinoma of the prostate is very rare histological variant and usually originates from the stomach, colon, and pancreas. This malignancy was first reported in 1979 and there have been case series with small numbers of patients and case reports in the literature. Signet cell carcinoma of the prostate has a poor outcome when compared to classic prostate adenocarcinoma. A case of primary signet cell carcinoma of the prostate that was treated with maximal androgen deprivation therapy with zoledronic acid is reported.